A Study of KK2269 in Adult Participants With Solid Tumors | MicrobiomeTrials← Back to trialsNCT06266299
A Study of KK2269 in Adult Participants With Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-01-18Est. Completion: 2029-03
Enrollment target: 101 participants Locations- Mayo Clinic Arizona, Scottsdale, Arizona, United States
- City Of Hope National Medical Center, Duarte, California, United States
- Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Washington University, St Louis, Missouri, United States
- The University of Texas Southwestern Medical Center, Dallas, Texas, United States
- University of Washington, Seattle, Washington, United States
- Aichi Cancer Center, Nagoya, Aichi-ken, Japan
- Fujita Health University Hospital, Toyoake, Aichi-ken, Japan
- National Cancer Center Hospital East, Kashiwa, Chiba, Japan
- National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
- Kurume University Hospital, Kurume, Fukuoka, Japan
- Kobe Minimally Invasive Cancer Center, Kobe, Hyōgo, Japan
- Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
- Kansai Medical University Hospital, Hirakata, Osaka, Japan
- Kindai University Hospital, Sakai, Osaka, Japan
Other microbiome trials you might be interested in
Advanced Solid TumorMetastatic Solid Tumor
The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine f…
Hamburg, GermanyEst. completion Dec 2026
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell Carcinoma
NHO Kinki-Chuo Chest Medical Center, Sakai, Osaka, JapanOsaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, JapanSaitama Prefectural Cancer Center, Shinden, Saitama, JapanShizuoka Cancer Center, Nagaizumi-chō, Shizuoka, JapanTochigi Cancer Center, Utsunomiya, Tochigi, JapanTokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyō-Ku, Tokyo, JapanNational Cancer Center Hospital, Chuo-ku, Tokyo, JapanCancer Institute Hospital of JFCR, Koto-Ku, Tokyo, JapanNational Hospital Organization Kyushu Cancer Center, Fukuoka, JapanHiroshima University Hospital, Hiroshima, JapanKumamoto University Hospital, Kumamoto, JapanNagasaki University Hospital, Nagasaki, JapanNiigata Cancer Center Hospital, Niigata, JapanOkayama University Hospital, Okayama, JapanOsaka International Cancer Institute, Osaka, JapanToyama University Hospital, Toyama, JapanLocally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Stage II Laryngeal Cancer AJCC v8
Stage II Lip and Oral Cavity Cancer AJCC v8
Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with ca…
Tucson, United StatesEst. completion Feb 1, 2033
Metastatic Breast Cancer
This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with met…
Duarte, United StatesEst. completion Sep 30, 2030